FindTrial
Sign In

Serum Lactate as a marker for severity at diagnosis of Sepsis

A PROSPECTIVE OBSERVATIONAL STUDY ON THE DIAGNOSTIC AND PROGNOSTIC VALUE OF SERUM LACTATE LEVEL IN PATIENTS DIAGNOSED WITH SEPSIS AT THE TIME OF ADMISSION

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022823
Enrollment
288
Registered
2020-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

None listed

Sponsors

Department of General Medicine Manipal Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted with suspected sepsis Patients aged more than 18 years

Exclusion criteria

Exclusion criteria: Pregnant/ Lactating Women Patients receiving treatment with Metformin/ Antiretroviral Therapy/ Antitubercular therapy/ Valproic Acid/ Ethylene Glycol poisoning , as these patients would have confounding increase in serum lactate levels independent of sepsis

Design outcomes

Primary

MeasureTime frame
All- Cause Mortality Number of Days of ICU stay/ Hospital Stay Requirement of Ventilator Support/ Renal Replacement Therapy Prolonged ICU stay/ Hospital Stay described as more than 7 dayTimepoint: 3 days: For Change in SOFA 7 days: As an indicator of Prolonged ICU Stay/ Hospital Stay Status at 30 days/ At discharge: As an indicator for Outcome—

Secondary

MeasureTime frame
1. Number of Days of ICU stay/ Hospital Stay 2. Requiring Ventilator Support/ Renal Replacement Therapy 3. Prolonged ICU stay/ Hospital Stay described as more than 7 daysTimepoint: 30 days/ At discharge—

Countries

India

Contacts

Public ContactKoushik S R

Manipal Hospitals

pais.prem@gmail.com9844130406

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026